Noble Capital analyst Joe Gomes initiated coverage of Marimed (MRMD) with an Outperform rating and 25c price target With operations in six states, MariMed is a vertically integrated seed-to-sale cannabis provider and “cannabis brand powerhouse” with leading market shares in current markets and significant expansion potential both within existing markets and new markets, the analyst tells investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRMD:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue